ScholarIQanswers from OpenAlex
PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
PaperCitations, authors & open-access status
PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy have?
ScholarIQcitation count
PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy has 423 citations in the OpenAlex counts ScholarIQ stores.
When was PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy published?
ScholarIQyear
PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy has 2021 year in the ScholarIQ index.
What is the open-access status of PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy?
ScholarIQoa status
PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy has gold oa status in the ScholarIQ index.
What is the DOI of PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy?
ScholarIQdoi
The DOI for PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy is on the source record.
What is the PMID of PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy?
ScholarIQpmid
The PMID for PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy is on the source record.
What is the OpenAlex record for PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy?
ScholarIQopenalex
The OpenAlex for PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy is on the source record.